Press Release Source: MedClean Technologies, Inc. MedClean Technologies Inc. CEO Publishes Letter to Shareholders President and CEO, Scott Grisanti, Publishes Letter Outlining Strategy, Market Opportunity and New Leadership Team Contacts: MedClean Technologies, Inc. Investor Contact: Kevin Dunphy                                                   Cameron Donahue Chief Financial Officer                                       Hayden IR (203) 798-1080                                                  (651) 653-1854 kdunphy@medcleantechnologies.com cameron@haydenir.com BETHEL, Conn., February 12, 2009 /PRNewswire-FirstCall/ — MedClean Technologies, Inc. (OTC BB: MCLN), a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste, today announced that its President and CEO, Scott Grisanti, has published a letter to shareholders. The letter, which is available on the Company’s website at www.medcleantechnologies.com, outlines MedClean’s new strategy, the expanded, $2 billion annual opportunity for the Company’s technology and expertise, its go-to-market strategy and the new leadership team in place to execute the strategic plan. Mr. Grisanti commented, “The letter published today and mailed to shareholders discusses the Company’s strategy, which is designed to achieve a break-out position in the rapidly growing industry of regulated medical waste processing. The annual market for regulated medical waste treatment and processing is $2 billion in the U.S. alone and MedClean possesses innovative technologies and provides unique solutions to meet the specific needs of the various segments of this market. The fundamentals of our strategic plan can be boiled down to three things: leadership, product and sales, and this letter addresses each of these topics. I am confident this letter will provide current and prospective shareholders with a comprehensive overview of the new MedClean Technologies.” About MedClean Technologies, Inc. MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean’s flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at http://www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov. Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward- looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2007, filed with the SEC on March 31, 2008, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.